Inhibiting mPGES-1 may repartition PGH2 to the remaining prostaglandin synthases, resulting in increased PGD2, PGF2α, and PGI2 generation in a murine BrafV600E melanoma model. The gene discussed is PTGES; the disease is melanoma.